SPD503 (Guanfacine Hydrochloride) in ADHD Plus Oppositional Symptoms

Completed · Phase 3 · Has a placebo group

Conditions studied: ADHD

In brief

To assess efficacy and safety of SPD503(guanfacine hydrochloride) in subjects with ADHD and oppositional symptoms.

Key facts

Study ID
NCT00367835
Run by
Shire
People needed
217
Starts
2006-12-04
Expected to finish
2008-01-04
Last updated by the study team
2021-06-14

Who can join

Age: 6 and older, up to 12. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.